We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Galapagos Extends Drug Discovery Collaboration with Lilly in Nuclear Hormone Receptor Research

News   Jan 17, 2008

 
Galapagos Extends Drug Discovery Collaboration with Lilly in Nuclear Hormone Receptor Research
 
 
 

RELATED ARTICLES

Accelerating Chemical Synthesis With "Turbo Chip"

News

Researchers have developed a process that facilitates and accelerates chemical synthesis and biological screening by combining all steps on a chip.

READ MORE

Enhancing the Infection-fighting Potential of Natural Products

News

A team has identified multiple promising new drug candidates to treat antibiotic-resistant infections, including the superbug MRSA.

READ MORE

Researchers Combat Drug-resistant Tuberculosis in the Lab

News

Scientists have found a way to reverse drug-resistant tuberculosis in the lab.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE